Skip to content

High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial

RecruitingNot applicableNCT06264297
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The management of chronic lumbar radicular and neuropathic pain is complex and the treatment success rates are low. Pulsed radiofrequency (PRF) has been described in these cases. In order to determine whether high-voltage PRF show better results than PRF a prospective, doble-blinded and randomized study is conducted in patients with chronic lumbar radicular and neuropathic pain.

Study details

Official title
High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial
Conditions
Sponsor
Consorci Sanitari de Terrassa
Start date
2023-02-20
Primary completion
2027-01
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
Spain
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients over 18 years of age. * Unilateral pain radiating to the lower extremity (with or without lumbar pain), which clinically corresponds to the path of the corresponding dermatomes. * Correlation between clinical symptoms and lesion observed by magnetic resonance imaging (MRI). * Radicular syndrome of three months or more of evolution. * Normal or pathological electromyogram (EMG). * Pain with neuropathic characteristics confirmed by the DN4 neuropathic pain questionnaire. * Patients with a previous positive block diagnosis. * Patients who have signed the informed consent document. Exclusion Criteria: * Patients under 18 years of age. * Patients with non-radicular low back pain. * MRI not consistent with the patient\'s symptoms. * Patients with peripheral neuropathy of the lower extremities. * Patients with a history or current diagnosis of serious mental disorder. * Patients with moderate or severe cognitive impairment, or evidence of acute or subacute confusional syndrome. * Infection at the puncture site. * Coagulation disorders. * Pregnant patients. * Patients who refuse to sign the informed consent document. * Patients allergic to radiological contrast.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06264297